Andere talen PreveCeutical Medical Inc.

Aandelen

CA74141E1043

Beurs gesloten - Canadian Securities Exchange Andere beurzen 21:43:03 07-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,025 ^CAD	+66,67%		0,00%	0,00%

2023	PreveCeutical Medical Inc. Start voorbereidingen voor preklinische studie voor haar ziekten & verkrijgt proof-of-concept dubbel gentherapieprogramma	CI
2023	PreveCeutical Medical Inc. rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PreveCeutical Announces Management Cease Trade Order	03/05
PreveCeutical Medical Inc. announced that it expects to receive CAD 0.25 million in funding	02/05
PreveCeutical Medical Inc. Initiates Preparation of Preclinical Study for Its Diseases & Obtains Proof-Of-Concept Dual Gene Therapy Program	04/12
PreveCeutical Medical Prepares For Proof of Concept Preclinical Study For Diabetes, Obesity Dual Gene Therapy Program	04/12
PreveCeutical Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11
PreveCeutical & Endosane Announce Update on Intranasal CBD Application	18-09-23
PreveCeutical Medical Inc. and Endosane Pharmaceuticals GmbH Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD and Pharmacologically Relevant Doses Following Intranasal CBD Application	18-09-23
PreveCeutical Medical Inc. Showcases Dynamic Evolution in AI Strategy	12-09-23
PreveCeutical Medical : Showcases Dynamic Evolution in AI Strategy	12-09-23
PreveCeutical Engages New to the Street for Production and Broadcasting Services	01-09-23
PreveCeutical Medical : Engages New to the Street for Production & Broadcasting Services	31-08-23
PreveCeutical Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25-08-23
PrevCeutical Medical Provides Update	24-07-23
PreveCeutical Medical Inc. Files Cyclic Peptides and Uses Thereof in EU and Australia	24-07-23
PreveCeutical Medical : Files Cyclic Peptides And Uses Thereof in the EU and Australia	24-07-23
PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use and Cyclic Peptides and Uses Thereof	29-06-23
PreveCeutical Medical Inc. Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereof	28-06-23
PreveCeutical Medical : Files Two Family Patents of Sol-Gel Cannabinoid Formulation And Antiviral Use & Cyclic Peptides And Uses Thereof	28-06-23
Preveceutical Medical Inc. Furthering the Progress of Its Patent Family Directed to Sol-Gel	30-05-23
PreveCeutical Medical : Sol-Gel and Uses thereof Patent Update	30-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen PreveCeutical Medical Inc.

Aandelen

PREV

CA74141E1043

Andere talen

Filters